Battle with current therapies that are limited for progressive multiple sclerosis (MS) in younger patients, this study provides a possible new avenue for treatment. Amidst significant risks of the study, it still shows promise to prevent progression for MS.
A team funded by Cancer Research UK and the Rosetrees Trust discovered that lung cancer can stay hidden for more than 20 years before they progress aggressively.
According to researchers, a Pfizer drug was effective in shrinking the tumor size in patients with a rare form of lung cancer.
Amgen Inc. announced that its blood cancer drug was capable of extending the lives of patients suffering from multiple myeloma.
Bayer's breast cancer drug failed to meet its primary endpoint goal in the Phase III trial.
According to Mayo Clinic doctors, a patient suffering from blood cancer was treated effectively with a massive dose of the measles vaccine.
According to a new study, drinking milk can slow down the progression of osteoarthritis.
Vitamin E may slow functional decline in patients suffering mild-to-moderate Alzheimer’s disease, a new study reveals. Functional decline includes problems with everyday tasks such as shopping, cooking and traveling.
Researchers found a gene variant common in African-Americans that appears to be responsible for speeding up the progression of chronic kidney disease.
Former U.S. President Bill Clinton was honored by the Harvard School of Public Health.
Researchers found that blood work might be able to help track the progress of cancer.
Researchers from the University of Sheffield School of Health and Related Research (ScHARR) are today making a series of recommendations for NHS mental health trusts to change the way they collect and use patient feedback to improve the quality of care for inpatients.